难治性痛风中西医结合治疗专家共识(2023)  

EXPERT CONSENSUS ON INTEGRATED CHINESE TRADITIONAL AND WESTERN MEDICINE THERAPY FOR REFRACTORY GOUT

作　　者：司可 陈颖[1] 王颜刚[1] SI Ke;CHEN Ying;WANG Yangang(Department of Endocrinology and Metabolism Diseases,The Affiliated Hospital of Qingdao University,Qingdao 266003,China)

机构地区：[1]青岛大学附属医院内分泌与代谢性疾病科,山东青岛266003

出　　处：《精准医学杂志》2023年第6期471-474,480,共5页Journal of Precision Medicine

基　　金：山东省卫生健康委员会中西医结合重大专项(S19-0009280000)。

摘　　要：痛风的发病率逐年升高,目前已成为中国仅次于糖尿病的第二大代谢类疾病,给患者的健康带来较大危害。难治性痛风患者血尿酸水平难以控制,病情较重,需引起人们的高度重视。基于此,本撰写组成员邀请国内对痛风诊治具有丰富经验的中西医专家,借鉴国内外痛风相关疾病的指南和共识,制订《难治性痛风中西医结合治疗专家共识》。本共识旨在规范难治性痛风的疾病管理流程,对难治性痛风中西医结合治疗的用药做出推荐,为难治性痛风的诊疗提供更具实操性的指导意见。The incidence rate of gout is increasing year by year,and it has now become the second largest metabolic di-sease after diabetes in China,bringing great harm to the health of patients.Patients with refractory gout often have poor control of blood uric acid level and severe disease conditions,which should be taken seriously by people.Therefore,we invited Chinese traditional and Western medical experts with rich experience in the diagnosis and treatment of gout in China to formulate Expert consensus on integrated traditional Chinese traditional and Western medicine therapy for refractory gout,with reference to the guidelines and consensus on gout-related diseases in China and globally.This consensus aims to standardize the disease management process of refractory gout,give recommendations to medications in integrated traditional Chinese traditional and Western medicine therapy for refractory gout,and provide more practical guidance for the diagnosis and treatment of refractory gout.

关 键 词：痛风 难治病 中西医结合疗法 疾病管理 专家共识 

分 类 号：R589.7[医药卫生—内分泌] R259[医药卫生—内科学]